T-cell Lymphoma Epidemiology: the Known and Unknown

被引:0
作者
Anh Phan
Rachel Veldman
Mary Jo Lechowicz
机构
来源
Current Hematologic Malignancy Reports | 2016年 / 11卷
关键词
T-cell lymphoma; Peripheral T-cell lymphoma; Cutaneous T-cell lymphoma; Epidemiology;
D O I
暂无
中图分类号
学科分类号
摘要
T-cell lymphoma, a collection of subtypes of Non-Hodgkin lymphoma, is a rare malignancy. The low prevalence of this disease has made it challenging to identify subtype-specific risk factors. Potential risk factors could enable us to identify high-risk patients and predict patient outcomes. Here, we report on the current epidemiologic and prognostic factors data associated with the individual subtypes both of peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) found in large cohort and case studies. Additionally, with recent findings, as well as updates in the new World Health Organization (WHO) classification of lymphoid neoplasms, we consider what this could do to change our approach to this group of diseases.
引用
收藏
页码:492 / 503
页数:11
相关论文
共 318 条
[1]  
Whang-Peng J(1982)Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL) Cancer 50 1539-1553
[2]  
Bunn PA(1979)Malignant lymphoma, T-cell type A distinct morphologic variant with large multilobated nuclei, with a report of four cases Am J Clin Pathol 72 540-550
[3]  
Knutsen T(1997)A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project Blood 89 3909-3918
[4]  
Matthews MJ(2016)The 2016 revision of the World Health Organization classification of lymphoid neoplasms Blood 127 2375-2390
[5]  
Schechter G(2008)International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes J Clin Oncol 26 4124-4130
[6]  
Pinkus GS(2014)Rationale and design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project J Natl Cancer Inst Monogr 2014 1-14
[7]  
Said JW(2004)Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification Ann Oncol 15 1467-1475
[8]  
Hargreaves H(2014)Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy Ann Oncol 25 2211-2217
[9]  
Swerdlow SH(2015)Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK’s Haematological Malignancy Research Network Br J Cancer 112 1575-1584
[10]  
Vose J(2016)Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States J Clin Oncol 34 963-971